| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.3945 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.5613 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.7283 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.7545 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.9361 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1.0225 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1.0674 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1.2802 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1.3824 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1.8851 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|